OraSure Technologies, Inc. (OSUR)

Market Cap	289.80M
Revenue (ttm)	224.26M
Net Income (ttm)	11.37M
Shares Out	74.59M
EPS (ttm)	0.15
PE Ratio	25.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	257,023
Open	3.800
Previous Close	3.810
Day's Range	3.800 - 3.910
52-Week Range	3.720 - 8.450
Beta	0.05
Analysts	Buy
Price Target	6.67 (+71.69%)
Earnings Date	Nov 6, 2024

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection d...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 12, 1986
• Employees: 638
• Stock Exchange: NASDAQ
• Ticker Symbol: OSUR
• Website: https://www.orasure.com

Analyst Forecast

According to 3 analysts, the average rating for OSUR stock is "Buy." The 12-month stock price forecast is $6.67, which is an increase of 71.69% from the latest price.

Price Target

$6.67

(71.69% upside)

Analyst Consensus: Buy